Quarterly Result22 May 2026, 03:16 pm
SMS Pharma: FY26 Revenue ₹886.87 Cr, Net Profit ₹2.43 Cr
AI Summary
SMS Pharmaceuticals Ltd's board approved the audited financial results for the year ended March 31, 2026. The company reported revenue from operations of ₹886.87 Cr and a net profit of ₹2.43 Cr. The board recommended a final dividend of ₹0.40 per equity share. They also approved the re-appointment of M/s. Adusumilli & Associates as Internal Auditors and the appointment of M/s. Annapragada & Co. as Cost Auditors for FY 2026-27. Additionally, the registered office is being shifted within Hyderabad.
Key Highlights
- SMS Pharma's FY26 revenue from operations stood at ₹886.87 Cr.
- The company reported a net profit of ₹2.43 Cr for FY26.
- A final dividend of ₹0.40 per equity share was recommended for FY26.
- M/s. Annapragada & Co. appointed as Cost Auditors for FY27.
- M/s. Adusumilli & Associates re-appointed as Internal Auditors for FY27.
Price Impact
More from SMSPHARMA